• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶3过表达与结肠癌细胞增殖及分化

HDAC3 overexpression and colon cancer cell proliferation and differentiation.

作者信息

Spurling Colleen C, Godman Cassandra A, Noonan Emily J, Rasmussen Theodore P, Rosenberg Daniel W, Giardina Charles

机构信息

Department of Molecular & Cell Biology, University of Connecticut, Storrs, Connecticut, USA.

出版信息

Mol Carcinog. 2008 Feb;47(2):137-47. doi: 10.1002/mc.20373.

DOI:10.1002/mc.20373
PMID:17849419
Abstract

An immunohistochemical analysis of human colorectal adenocarcinomas showed that cancer cells express widely varying levels of HDAC3. The SW480 colon cancer cell line was found to express high levels of HDAC3 compared to other colon cancer cell lines. p21 was poorly induced in SW480 cells relative to the lower HDAC3-expressing HT-29 cells. RNAi-induced reduction of HDAC3 in SW480 cells increased their constitutive, butyrate-, TSA-, and TNF-alpha-induced expression of p21, but did not cause all the gene expression changes induced upon general histone deacetylase (HDAC) inhibition. SW480 cells with lower HDAC3 expression appeared to be poised for gene expression responses with increased histone H4-K12 acetylation, but not K5, K8, or K16 acetylation. Even though p21 was readily activated in HT29 cells, HDAC3 siRNA nonetheless stimulated p21 expression in these cells to a greater degree than HDAC1 and HDAC2 siRNA. SW480 cells with lower HDAC3 levels displayed an enhanced cell cycle arrest and growth inhibition by butyrate, but without changes in apoptosis or sensitivity to chemotherapeutic agents. As reported for other colon cancer cell lines, butyrate induced the rapid downregulation of the secretory cell differentiation markers mucin 2 and intestinal trefoil factor in SW480 cells. Interestingly, selective HDAC3 inhibition was sufficient to downregulate these genes. Our data support a central role for HDAC3 in regulating the cell proliferation and differentiation of colon cancer cells and suggest a potential mechanism by which colon cancers may become resistant to luminal butyrate.

摘要

对人类结肠腺癌的免疫组织化学分析表明,癌细胞表达的HDAC3水平差异很大。与其他结肠癌细胞系相比,SW480结肠癌细胞系被发现表达高水平的HDAC3。相对于低表达HDAC3的HT - 29细胞,p21在SW480细胞中诱导较差。RNA干扰诱导SW480细胞中HDAC3的减少增加了其组成性、丁酸盐、曲古抑菌素A和肿瘤坏死因子-α诱导的p21表达,但并未引起一般组蛋白去乙酰化酶(HDAC)抑制所诱导的所有基因表达变化。HDAC3表达较低的SW480细胞似乎已准备好对基因表达作出反应,其组蛋白H4 - K12乙酰化增加,但K5、K8或K16乙酰化未增加。尽管p21在HT29细胞中很容易被激活,但HDAC3 siRNA在这些细胞中对p21表达的刺激程度仍大于HDAC1和HDAC2 siRNA。HDAC3水平较低的SW480细胞表现出丁酸盐增强的细胞周期停滞和生长抑制,但细胞凋亡或对化疗药物的敏感性没有变化。正如对其他结肠癌细胞系的报道一样,丁酸盐诱导SW480细胞中分泌细胞分化标志物粘蛋白2和肠三叶因子的快速下调。有趣的是,选择性HDAC3抑制足以下调这些基因。我们的数据支持HDAC3在调节结肠癌细胞的细胞增殖和分化中起核心作用,并提示结肠癌可能对肠腔丁酸盐产生抗性的潜在机制。

相似文献

1
HDAC3 overexpression and colon cancer cell proliferation and differentiation.组蛋白去乙酰化酶3过表达与结肠癌细胞增殖及分化
Mol Carcinog. 2008 Feb;47(2):137-47. doi: 10.1002/mc.20373.
2
Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3.结肠癌细胞维持低水平的丙酮酸以避免因抑制HDAC1/HDAC3而导致的细胞死亡。
Biochem J. 2009 Jan 1;417(1):379-89. doi: 10.1042/BJ20081132.
3
Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.I 类组蛋白去乙酰化酶的表达对人类结直肠癌具有独立的预后影响:I 类组蛋白去乙酰化酶在体外和体内的特定作用。
Clin Cancer Res. 2008 Mar 15;14(6):1669-77. doi: 10.1158/1078-0432.CCR-07-0990.
4
Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.组蛋白去乙酰化酶抑制剂诱导的细胞凋亡涉及1型鲟钙蛋白激活。
Exp Cell Res. 2008 Oct 1;314(16):2975-84. doi: 10.1016/j.yexcr.2008.07.002. Epub 2008 Jul 9.
5
Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation.姜黄素是一种有效的抗肿瘤试剂,是一种调节B淋巴细胞瘤细胞系Raji增殖的新型组蛋白脱乙酰酶抑制剂。
Acta Pharmacol Sin. 2005 May;26(5):603-9. doi: 10.1111/j.1745-7254.2005.00081.x.
6
The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.组蛋白脱乙酰酶抑制剂丁酸盐通过p21/WAF-1依赖性机制下调人结肠癌细胞中细胞周期蛋白B1基因的表达。
Am J Physiol Gastrointest Liver Physiol. 2005 Oct;289(4):G696-703. doi: 10.1152/ajpgi.00575.2004.
7
Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.组蛋白去乙酰化酶(HDAC)过表达在卵巢癌中的特定作用:HDAC1 增强细胞增殖,HDAC3 通过下调 E-钙黏蛋白刺激细胞迁移。
Int J Cancer. 2010 Sep 1;127(6):1332-46. doi: 10.1002/ijc.25151.
8
Differential display cloning of a novel human histone deacetylase (HDAC3) cDNA from PHA-activated immune cells.从PHA激活的免疫细胞中差异显示克隆新型人类组蛋白脱乙酰基酶(HDAC3)cDNA
Biochem Biophys Res Commun. 1998 Jan 26;242(3):648-52. doi: 10.1006/bbrc.1997.8033.
9
Acyclic retinoid, a novel synthetic retinoid, induces growth inhibition, apoptosis, and changes in mRNA expression of cell cycle- and differentiation-related molecules in human colon carcinoma cells.非环状维甲酸,一种新型合成维甲酸,可诱导人结肠癌细胞生长抑制、凋亡以及细胞周期和分化相关分子的mRNA表达变化。
Int J Oncol. 2006 May;28(5):1193-9.
10
Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.吡咯烷二硫代氨基甲酸盐抑制组蛋白乙酰化并诱导人白血病细胞凋亡需要铜离子(Cu2+)。
Chem Biol Interact. 2008 Jan 10;171(1):26-36. doi: 10.1016/j.cbi.2007.09.004. Epub 2007 Sep 15.

引用本文的文献

1
Histone Deacetylase Inhibitors Promote the Anticancer Activity of Cisplatin: Mechanisms and Potential.组蛋白去乙酰化酶抑制剂增强顺铂的抗癌活性:作用机制与潜力
Pharmaceuticals (Basel). 2025 Apr 11;18(4):563. doi: 10.3390/ph18040563.
2
Epithelial-Mesenchymal Plasticity and Epigenetic Heterogeneity in Cancer.癌症中的上皮-间质可塑性与表观遗传异质性
Cancers (Basel). 2024 Sep 27;16(19):3289. doi: 10.3390/cancers16193289.
3
Effect of valproic acid on histone deacetylase expression in oral cancer (Review).丙戊酸对口腔癌中组蛋白去乙酰化酶表达的影响(综述)
Oncol Lett. 2024 Mar 7;27(5):197. doi: 10.3892/ol.2024.14330. eCollection 2024 May.
4
Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer.组蛋白去乙酰化酶6及组蛋白去乙酰化酶6抑制在结直肠癌中的作用
Pharmaceutics. 2023 Dec 29;16(1):54. doi: 10.3390/pharmaceutics16010054.
5
Systematic analysis of histone acetylation regulators across human cancers.系统性分析人类癌症中的组蛋白乙酰化调控因子。
BMC Cancer. 2023 Aug 8;23(1):733. doi: 10.1186/s12885-023-11220-7.
6
Targeting histone deacetylases for cancer therapy: Trends and challenges.以组蛋白去乙酰化酶为靶点进行癌症治疗:趋势与挑战。
Acta Pharm Sin B. 2023 Jun;13(6):2425-2463. doi: 10.1016/j.apsb.2023.02.007. Epub 2023 Feb 18.
7
Repurposing of neprilysin inhibitor 'sacubitrilat' as an anti-cancer drug by modulating epigenetic and apoptotic regulators.将 Neprilysin 抑制剂“沙库巴曲”通过调节表观遗传和凋亡调节剂重新用于抗癌药物。
Sci Rep. 2023 Jun 19;13(1):9952. doi: 10.1038/s41598-023-36872-0.
8
Post-translational modifications of histones: Mechanisms, biological functions, and therapeutic targets.组蛋白的翻译后修饰:机制、生物学功能及治疗靶点。
MedComm (2020). 2023 May 20;4(3):e292. doi: 10.1002/mco2.292. eCollection 2023 Jun.
9
Post-Translational Modifications by Lipid Metabolites during the DNA Damage Response and Their Role in Cancer.脂质代谢物在 DNA 损伤反应中的翻译后修饰及其在癌症中的作用。
Biomolecules. 2022 Nov 8;12(11):1655. doi: 10.3390/biom12111655.
10
Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors.克服实体瘤中氟嘧啶耐药性的表观遗传学方法。
Cancers (Basel). 2022 Jan 29;14(3):695. doi: 10.3390/cancers14030695.